
Created, owned and operated by its members, the Canadian Stroke Consortium (CSC) is the nation's premiere neurologist network. We are an academic alliance committed to the pursuit of anti-stroke therapies by designing and/or conducting research projects and clinical trials. Many of our members are opinion leaders in Canadian and international stroke research and clinical practice. Together with the pharmaceutical industry, our combined efforts continue to support emerging trends in CNS therapeutic development.

| Board of Directors | |
|---|---|
| Chairman: | Dr. Philip Teal (Vancouver) |
| Board Members: |
|
| Ex-Officio | Dr. Michael Hill (Calgary) - Chairman of Research and Development Committee |
| Credentials Committee | |
|---|---|
| Members: |
|
| Business Manager | |
| Donna Huber | |
MembershipOver 150 neurologists |
Clinical Trial Sitesover 60 |
Primary Source of FundingClient Sponsorship Agreements |
AffiliationsCanadian Congress of Neurological Sciences |
||
InsuranceHealthcare Insurance Reciprocal of Canada (HIROC) |
AuditorsGrant Thornton Chartered Accounts |
Legal CounselAlan WestGowlings, Lafleur, Henderson |
| Committees |
|---|
| Education Committee |
|
| R & D Committee |
|
| Ethics Committee |
|
![]()
![]() |
![]()
http://www.strokeconsortium.ca
copyright © 1997-2010 Canadian Stroke Consortium |
revised 13-January-2010 |
contact CSC: strokeconsortium [at] on [dot] aibn [dot] com
website maintained by Soft Dog WebWorks |
contact webmanager: webmanager-csc [at] softdog [dot] ca